FDA
-
-
-
-
-
-
-
Intensity Therapeutics Reports INVINCIBLE-4, Presurgical Triple-Negative Breast Cancer Study Update
-
-
-
-
-
-
-
Intensity Therapeutics Provides Business Update Highlighting Key Achievements with Lead Drug Candidate INT230-6
-
-
-
-
-
-
-
Intensity Therapeutics Provides Business Update Reflecting Progress in Phase 3 Sarcoma Program
-
-
-
-
-
328,513 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

